To include your compound in the COVID-19 Resource Center, submit it here.

Amgen, Immunomedics deal

IMMU said it is in talks with partner AMGN about the possible return to IMMU

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE